国际肿瘤学杂志

国际肿瘤学杂志 ›› 2012, Vol. 39 ›› Issue (3): 234-236.

• 综述 • 上一篇    下一篇

卵巢癌顺铂耐药分子生物学研究进展

韩雪川,樊杨   

  1. 750021银川，宁夏自治区人民医院妇产科
  • 出版日期:2012-03-08 发布日期:2012-02-24
  • 通讯作者: 樊杨,E-mail: yangf0803@126.com E-mail:yangf0803@126.com
  • 基金资助:

    国家自然科学基金资助项目（81060215）

Molecular mechanism of cisplatin resistance in ovarian cancer

HAN  Xue-Chuan, FAN  Yang   

  1. Department of Obstetrics and Gynecology, Ningxia People’s Hospital, Yinchuan 750021, China
  • Online:2012-03-08 Published:2012-02-24
  • Contact: FAN Yang, E-mail: yangf0803@126.com E-mail:yangf0803@126.com

PDF

1950

摘要： 化疗耐药是有效治疗卵巢癌的重大障碍。卵巢癌耐药是多因素、多因子共同作用的结果,耐药相关基因的深入研究为从根本上逆转肿瘤耐药提供了新的思路。

关键词: color: green, font-family: 宋体, mso-ansi-language: EN-US, mso-fareast-language: ZH-CN, mso-bidi-language: AR-SA, mso-bidi-font-family: 'Times New Roman', mso-font-kerning: 1.0pt">卵巢肿瘤, 药物疗法, 顺铂

Abstract: Chemotherapy resistance is a great obstacle for effective treatment of ovarian cancer. Drug resistance of ovarian cancer is the results of combined action of multi- factors. Further study of drug resistance-related genes can provide new ideas for reversing drug resistance fundamentally.

Key words: color: green, font-family: "Times New Roman", mso-ansi-language: EN-US, mso-fareast-language: ZH-CN, mso-bidi-language: AR-SA, mso-fareast-font-family: 宋体">Ovarian neoplasms, Drug therapy, Cisplatin